← All organizations

Myonexus Therapeutics

For profit

Also known as: Myonexus Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 10, 2018

Acquired by Sarepta Therapeutics on Feb 27, 2019

Timeline

2010s

Feb 1, 2017
Myonexus Therapeutics— Founded
Feb 27, 2019
Sarepta Therapeutics— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

bidridistrogene xeboparvovec

Indications

Studied for

Recent trials (1)

NCT03652259CollaboratorPhase 1/Phase 2Oct 10, 2018

Details

Founded: Columbus, OH, US Feb 1, 2017
Last known activity: Oct 10, 2018